Efficacy of intra-articular polynucleotides associated with hyaluronic acid vs hyaluronic acid alone in the treatment of knee osteoarthritis: A systematic review and meta-analysis of randomized clinical trial
- PMID: 32541518
- PMCID: PMC7302631
- DOI: 10.1097/MD.0000000000020689
Efficacy of intra-articular polynucleotides associated with hyaluronic acid vs hyaluronic acid alone in the treatment of knee osteoarthritis: A systematic review and meta-analysis of randomized clinical trial
Erratum in
-
Study Protocol Titles: Erratum.Medicine (Baltimore). 2020 Aug 14;99(33):e21984. doi: 10.1097/MD.0000000000021984. Medicine (Baltimore). 2020. PMID: 32872085 Free PMC article. No abstract available.
Abstract
Background: The reduced range of motion and pain are the most characteristic clinical features of osteoarthritis (OA). Hyaluronic acid (HA), which is one of the infiltrative therapies for OA treatment, and polynucleotides (PNs), which is a DNA-derived macromolecule favored cell growth and collagen production, are an ongoing debate in clinical effectiveness.
Methods: We plan to perform a systematic review and meta-analysis of randomized clinical trial to evaluate efficacy of intra-articular polynucleotides associated with hyaluronic acid versus hyaluronic acid alone in the treatment of knee osteoarthritis. We will search PubMed, EMBASE, Cochrane Library using a comprehensive strategy. The related conference proceedings and reference lists of the included studies will also be checked to identify additional studies. Two reviewers will screen retrieved records, extract information and assess the risk of bias independently. Stata v15.1 software will be used to conduct data synthesis.
Results: This study will be submitted to a peer-reviewed journal for publication.
Conclusion: We hope it will provide a relatively comprehensive reference for clinical practice and future relevant clinical trials.
Ethics and dissemination: Ethics approval and patient consent are not required, as this study is a systematic review and meta-analysis.
Prospero registration number: CRD42020167678.
Conflict of interest statement
The authors report no conflicts of interest.
References
-
- Veronesi F, Giavaresi G, Maglio M, et al. Chondroprotective activity of Nacetyl phenylalanine glucosamine derivative on knee joint structure and inflammation in a murine model of osteoarthritis. Osteoarthr Cartil 2017;25:589–99. - PubMed
-
- Gallagher B, Tjoumakaris FP, Harwood MI, et al. Chondroprotection and the prevention of osteoarthritis progression of the knee: a systematic review of treatment agents. Am J Sports Med 2015;43:734–44. - PubMed